These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 28388547)

  • 1. Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545.
    Abassi Z; Hamoud S; Hassan A; Khamaysi I; Nativ O; Heyman SN; Muhammad RS; Ilan N; Singh P; Hammond E; Zaza G; Lupo A; Onisto M; Bellin G; Masola V; Vlodavsky I; Gambaro G
    Oncotarget; 2017 May; 8(21):34191-34204. PubMed ID: 28388547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury.
    Masola V; Zaza G; Gambaro G; Onisto M; Bellin G; Vischini G; Khamaysi I; Hassan A; Hamoud S; Nativ O; Heyman SN; Lupo A; Vlodavsky I; Abassi Z
    PLoS One; 2016; 11(7):e0160074. PubMed ID: 27467172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of Zeb2 ameliorates progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia-reperfusion injury.
    Inotani S; Taniguchi Y; Nakamura K; Nishikawa H; Matsumoto T; Horino T; Fujimoto S; Sano S; Yanagita M; Terada Y
    Nephrol Dial Transplant; 2022 Feb; 37(3):454-468. PubMed ID: 34724064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.
    Weissmann M; Bhattacharya U; Feld S; Hammond E; Ilan N; Vlodavsky I
    Matrix Biol; 2019 Apr; 77():58-72. PubMed ID: 30096360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein promotes acute kidney injury by impairing G1/S-dependent tubular epithelium cell regeneration.
    Tang Y; Huang XR; Lv J; Chung AC; Zhang Y; Chen JZ; Szalai AJ; Xu A; Lan HY
    Clin Sci (Lond); 2014 May; 126(9):645-59. PubMed ID: 24206243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Protective Pathways Activated in Kidneys of αMUPA Transgenic Mice Following Ischemia\Reperfusion-Induced Acute Kidney Injury.
    Alkhaleq HA; Karram T; Fokra A; Hamoud S; Kabala A; Abassi Z
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase inhibition attenuates atherosclerosis progression and liver steatosis in E
    Muhammad RS; Abu-Saleh N; Kinaneh S; Agbaria M; Sabo E; Grajeda-Iglesias C; Volkova N; Hamoud S
    Atherosclerosis; 2018 Sep; 276():155-162. PubMed ID: 30075439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma model.
    Hammond E; Brandt R; Dredge K
    PLoS One; 2012; 7(12):e52175. PubMed ID: 23300607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression.
    Singh P; Blatt A; Feld S; Zohar Y; Saadi E; Barki-Harrington L; Hammond E; Ilan N; Vlodavsky I; Chowers Y; Half E
    Neoplasia; 2017 Mar; 19(3):175-184. PubMed ID: 28147305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephroprotective effect of heparanase in experimental nephrotic syndrome.
    Assady S; Alter J; Axelman E; Zohar Y; Sabo E; Litvak M; Kaplan M; Ilan N; Vlodavsky I; Abassi Z
    PLoS One; 2015; 10(3):e0119610. PubMed ID: 25786136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity.
    Masola V; Zaza G; Secchi MF; Gambaro G; Lupo A; Onisto M
    Biochim Biophys Acta; 2014 Sep; 1843(9):2122-8. PubMed ID: 24937189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition.
    Masola V; Onisto M; Zaza G; Lupo A; Gambaro G
    J Transl Med; 2012 Oct; 10():213. PubMed ID: 23095131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Klotho gene-modified BMSCs showed elevated antifibrotic effects by inhibiting the Wnt/β-catenin pathway in kidneys after acute injury.
    Zhang F; Wan X; Cao YZ; Sun D; Cao CC
    Cell Biol Int; 2018 Dec; 42(12):1670-1679. PubMed ID: 30358003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronidase inhibitor sHA2.75 alleviates ischemia-reperfusion-induced acute kidney injury.
    Zhang Y; Zhao H; Zhang J
    Cell Cycle; 2024 Feb; 23(3):248-261. PubMed ID: 38526145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of miR-21 by Ghrelin Ameliorates Ischemia/Reperfusion-Induced Acute Kidney Injury by Inhibiting Inflammation and Cell Apoptosis.
    Zhang W; Shu L
    DNA Cell Biol; 2016 Aug; 35(8):417-25. PubMed ID: 27152763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild elevation of urinary biomarkers in prerenal acute kidney injury.
    Doi K; Katagiri D; Negishi K; Hasegawa S; Hamasaki Y; Fujita T; Matsubara T; Ishii T; Yahagi N; Sugaya T; Noiri E
    Kidney Int; 2012 Nov; 82(10):1114-20. PubMed ID: 22854644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice.
    Toyohara T; Mae S; Sueta S; Inoue T; Yamagishi Y; Kawamoto T; Kasahara T; Hoshina A; Toyoda T; Tanaka H; Araoka T; Sato-Otsubo A; Takahashi K; Sato Y; Yamaji N; Ogawa S; Yamanaka S; Osafune K
    Stem Cells Transl Med; 2015 Sep; 4(9):980-92. PubMed ID: 26198166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications.
    Barash U; Lapidot M; Zohar Y; Loomis C; Moreira A; Feld S; Goparaju C; Yang H; Hammond E; Zhang G; Li JP; Ilan N; Nagler A; Pass HI; Vlodavsky I
    J Natl Cancer Inst; 2018 Oct; 110(10):1102-1114. PubMed ID: 29579286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular communication network factor 2 (CCN2) promotes the progression of acute kidney injury to chronic kidney disease.
    Inoue T; Kusano T; Amano H; Nakamoto H; Okada H
    Biochem Biophys Res Commun; 2019 Sep; 517(1):96-102. PubMed ID: 31320136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of apoptosis-stimulating protein two of p53 ameliorates acute kidney injury induced by ischemia reperfusion in mice through upregulation of autophagy.
    Ji J; Zhou X; Xu P; Li Y; Shi H; Chen D; Li R; Shi H
    J Cell Mol Med; 2019 Apr; 23(4):2457-2467. PubMed ID: 30675758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.